Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,619.95
+13.55 (0.84%)
At close: Aug 21, 2026

Aurobindo Pharma Company Description

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas.

It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products.

The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Aurobindo Pharma Limited
CountryIndia
Founded1986
IndustryPharmaceutical Preparations
Employees29,209
CEOKambam Reddy

Contact Details

Address:
Galaxy, Plot No. 1
Hyderabad, 500032
India
Phone91 40 6672 5000
Websiteaurobindo.com

Stock Details

Ticker Symbol524804
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Kambam ReddyChief Executive Officer
Santhanam SubramanianChief Financial Officer